Cooper Companies’ Stock Dips Despite Steady Growth Prospects

Valued at a market cap of $16.8 billion, The Cooper Companies, Inc. (COO) operates as a specialty medical device firm focused on developing, manufacturing, and marketing products for contact lens wearers. Headquartered in San Ramon, California, the company primarily addresses vision issues such as astigmatism, presbyopia, and ocular dryness.

Market Position and Growth Strategy

Companies with a valuation of $10 billion or more are deemed “large-cap stocks,” and COO fits this category nicely with a market cap that demonstrates its size and influence in the medical instruments and supplies sector. With a presence in over 100 countries, the company enjoys steady demand for its products, supported by a recession-resistant business model. COO drives growth through continuous innovation and strategic acquisitions, which expand its product offerings and market reach.

Recent Performance Overview

Despite these strengths, the company’s stock has declined by 25.2% from its 52-week high of $112.38, reached on September 16, 2024. In the past three months, COO shares have fallen by 9.4%, significantly underperforming the Health Care Select Sector SPDR Fund (XLV), which gained 5.6% during the same period.

Assessing longer-term performance, COO has seen a 16.3% decrease over the last 52 weeks, whereas XLV experienced a modest gain of 1.2%. Year-to-date, COO shares are down nearly 8.6%, while XLV is up approximately 7%.

Trading Indicators and Earnings Report

COO has been trading below its 200-day moving average since mid-December 2024, with minor fluctuations. Additionally, the stock has remained below its 50-day moving average since late October 2024.

On March 6, COO announced its Q1 earnings, which led to a 6.6% drop in the stock price the following day. The company reported revenue of $964.7 million—a year-over-year increase of 3.6%—but this fell 1.6% short of analyst expectations. A key driver of this revenue miss was a slump in CooperVision’s revenue in the Asia-Pacific region. Conversely, adjusted earnings grew 8.2% year-over-year to $0.92 per share, exceeding the consensus estimate of $0.91, supported by higher adjusted gross and operating profit margins, reflecting better efficiency and cost management.

Future Expectations

Looking ahead to fiscal 2025, Cooper Companies anticipates adjusted earnings per share (EPS) between $3.94 and $4.02, with projected revenues ranging from $4.1 billion to $4.2 billion, indicating organic growth of 6% to 8%.

Comparative Analysis

Cooper Companies’ recent stock performance stands in stark contrast to its competitor, Alcon Inc. (ALC), which has increased by 10.5% over the past 52 weeks and 8.8% on a year-to-date basis.

Analysts’ Outlook

Despite the recent underperformance compared to its sector, analysts remain cautiously optimistic about COO’s future. The stock holds a consensus rating of “Moderate Buy” from 16 analysts, with a mean price target of $110.36 that suggests an ambitious 31.3% upside from its current levels.

On the date of publication, Neharika Jain did not hold positions in any securities mentioned in this article. All information and data is for informational purposes only. For details, please review the Barchart Disclosure Policy here.

More news from Barchart

The views and opinions expressed herein are those of the author and do not reflect those of Nasdaq, Inc.